SCHEMBL2795302

SCHEMBL2795302

CC1(C)CNCCC1(O)Cc1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.41
SLC6A3 Q01959 3/20 0.41
KCNH2 Q12809 2/20 0.41
CYP2D6 P10635 2/20 0.41
SLC6A4 P31645 2/20 0.41
TRPA1 O75762 2/20 0.35
IRAK1 P51617 2/20 0.34
IRAK4 Q9NWZ3 2/20 0.34
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
CHRND Q07001 1/20 0.33
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
CCNT1 O60563 1/20 0.31
CDK9 P50750 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2798436 0.85 DRD2 (0.42) SLC6A2SLC6A3SLC6A4TRPA1IRAK1
SCHEMBL2798879 0.78 SLC6A2 (0.45) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4
SCHEMBL1574254 0.74 SLC6A2 (0.41) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4
SCHEMBL2159303 0.73 SLC6A3 (0.41) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4
SCHEMBL13282833 0.72
Hydrochloric Acid SCHEMBL7964557 0.72 SLC6A2 (0.40) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4
SCHEMBL29057868 0.72 SLC6A2 (0.40) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4
Bromide SCHEMBL5807570 0.71 SLC6A2 (0.39) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4
Bromide SCHEMBL5807574 0.71 SLC6A2 (0.39) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4
SCHEMBL3353843 0.71 CYP2D6 (0.42) SLC6A2SLC6A3KCNH2CYP2D6SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010077915-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-07-08 WO disclosed
WO-2010077915-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-07-08 WO disclosed
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS KHAMRAI UTTAM 2010-07-01 US disclosed
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS KHAMRAI UTTAM 2010-07-01 US disclosed
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS KHAMRAI UTTAM 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS CCR1, CCR5, CCR3 SLC6A2 4553/4885SLC6A3 3889/4885KCNH2 4299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.